600196 Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.
Closed 04-18 15:00:00
23.88
-0.07
-0.29%
| High24.02 | Low23.76 | Vol5.81M |
| Open23.87 | D1 Closing23.95 | Amplitude1.09% |
| Mkt Cap63.78B | Tradable Cap50.58B | Total Shares2.67B |
| T/O139.00M | T/O Rate0.27% | Tradable Shares2.12B |
| P/B1.35 | ROE-- | EPS0.00 |
| 52wk High-- | 52wk Low-- | P/E-- |
| Dividend-- | Div.Yield-- | ROA-- |
Loading ...
Shanghai Fosun Pharmaceutical to Sell 55% Stake in Investment Firm
MT Newswires Live · 04-14
BRIEF-Shanghai Fosun Pharma Agreed To Sell Equity Interest In Shanghai Fujian
Reuters · 04-11
Shanghai Fosun Pharma - Agreed to Sell 29.00%, 25.90% and 0.10% Equity Interest in Shanghai Fujian to Fosun High Tech, Others
THOMSON REUTERS · 04-11
Fosun Pharmaceutical Gets Clinical Trial Approval for Schizophrenia Drug
MT Newswires Live · 04-08
Fosun Pharmaceutical Unit Gets China Nod for Schizophrenia Drug Trial
MT Newswires Live · 04-08
BRIEF-Shanghai Fosun Pharma Says Approval Received From NMPA For Clinical Trial Of CMC-2310 Oral Soluble Film
Reuters · 04-07
Shanghai Fosun Pharma - Received Approval From Nmpa for the Clinical Trial of Cmc-2310 Oral Soluble Film
THOMSON REUTERS · 04-07
Shanghai Fosun Pharmaceutical Raises Stake in United Health Insurance; Shares Rise
MT Newswires Live · 04-01
Shanghai Fosun Pharma Says Co Will Hold 20.1% Stake in the Firm After the Investment
THOMSON REUTERS · 03-31
BRIEF-Fosun Pharma To Invest In Health Insurance Firm With IFC, ADB
Reuters · 03-31
Shanghai Fosun Pharma Says Co, Ifc, Asian Development Bank Plan to Buy Newly Issued Shares From Health Insurance Firm for 270 Mln Yuan Each
THOMSON REUTERS · 03-31
Fosun Pharmaceutical-Owned Gland Pharma to Invest 1.6 Billion Yuan in Indian Mutual Funds, Bonds
MT Newswires Live · 03-26
China's NAFMII Accepts Fosun Pharma's Application to Issue Up to 10 Billion Yuan Bonds
MT Newswires Live · 03-26
Fosun Pharma Announces 2024 Annual Results
THOMSON REUTERS · 03-26
Press Release: Fosun Pharma Announces 2024 Annual Results
Dow Jones · 03-26
Shanghai Fosun Pharmaceutical Group FY Operating Cash Flow RMB 4,477 Million
THOMSON REUTERS · 03-25
Shanghai Fosun Pharmaceutical Says 2024 Net Profit up 16.1% Y/Y
THOMSON REUTERS · 03-25
BRIEF-Shanghai Fosun Pharmaceutical's 2024 Net Profit Up 16.1% Y/Y
Reuters · 03-25
Shanghai Fosun Pharma - Registered Amount of Medium Term Notes of Company Is RMB4 Bln.
THOMSON REUTERS · 03-25
Shanghai Fosun Pharmaceutical (Group)'s Subsidiary PNH Drug Gets NMPA's Nod for Clinical Trials; Shares Rise 4%
MT Newswires Live · 03-14
Introduction
Company Name.
上海复星医药(集团)股份有限公司
Industry:
医药制造业
Listing Date:
1998-08-07
Main Business:
上海复星医药(集团)股份有限公司的主营业务是制药、医疗器械、医学诊断、医疗健康服务。公司的主要产品是抗肿瘤及免疫调节核心产品、抗感染核心产品、代谢及消化系统核心产品、心血管系统核心产品、中枢神经系统核心产品、原料药和中间体核心产品。由中国国际科技促进会、药智网等主办的“2024中国药品研发实力排行榜”系列榜单，本集团荣登研发综合实力排行榜第4位、化药研发实力排行榜第3位、生物药研发实力排行榜第4位。
Issue price:
7.15
Invest in Global Markets with Tiger Brokers!Open App